Supplementary Table S4 from Evolution and Co-occurrence of PI3K Pathway Gene Mutations in Endometrial Carcinoma Molecular Subtypes at the Single-Cell Level

Documenti analoghi

• Supplementary Figure 1 from Antitumor Effect of Farletuzumab Ecteribulin in Molecular Subtypes of Endometrial Cancer Patient-Derived Xenograft Models
  di: Shigehiro Yagishita (15088446)
  Pubblicazione: (2025)
• Supplementary Figure 2 from Antitumor Effect of Farletuzumab Ecteribulin in Molecular Subtypes of Endometrial Cancer Patient-Derived Xenograft Models
  di: Shigehiro Yagishita (15088446)
  Pubblicazione: (2025)
• Supplementary Figure 3 from Antitumor Effect of Farletuzumab Ecteribulin in Molecular Subtypes of Endometrial Cancer Patient-Derived Xenograft Models
  di: Shigehiro Yagishita (15088446)
  Pubblicazione: (2025)
• Supplementary Figure 4 from Antitumor Effect of Farletuzumab Ecteribulin in Molecular Subtypes of Endometrial Cancer Patient-Derived Xenograft Models
  di: Shigehiro Yagishita (15088446)
  Pubblicazione: (2025)
• Supplementary Table 1 from Spatiotemporal Immune Landscape and Long-term Immune Memory in POLE-Mutant Endometrial Cancer at the Single-Cell Level
  di: Koen Brummel (20887450)
  Pubblicazione: (2025)